What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Bacteria
His primary scientific interests are in Neisseria gonorrhoeae, Microbiology, Antibiotic resistance, Gonorrhea and Genetics.
His work deals with themes such as Multiple drug resistance, Internal medicine, Cefixime, Ceftriaxone and Typing, which intersect with Neisseria gonorrhoeae.
His Microbiology research incorporates elements of Neisseria, Multilocus sequence typing, Molecular epidemiology and Virology.
The various areas that he examines in his Antibiotic resistance study include Antimicrobial, Drug resistance, Azithromycin and Intensive care medicine.
His Intensive care medicine study combines topics in areas such as Surgery, Immunology, Beta lactam antibiotics and Global health, Public health.
His study looks at the relationship between Genetics and fields such as Chlamydia trachomatis, as well as how they intersect with chemical problems.
His most cited work include:
- Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting (851 citations)
- Antimicrobial Resistance in Neisseria gonorrhoeae in the 21st Century: Past, Evolution, and Future (526 citations)
- Is Neisseria gonorrhoeae Initiating a Future Era of Untreatable Gonorrhea?: Detailed Characterization of the First Strain with High-Level Resistance to Ceftriaxone (494 citations)
What are the main themes of his work throughout his whole career to date?
Magnus Unemo focuses on Neisseria gonorrhoeae, Microbiology, Antibiotic resistance, Virology and Antimicrobial.
His research in Neisseria gonorrhoeae focuses on subjects like Azithromycin, which are connected to Mycoplasma genitalium.
His Microbiology study combines topics from a wide range of disciplines, such as Molecular epidemiology and Multilocus sequence typing.
His study in Antibiotic resistance is interdisciplinary in nature, drawing from both Multiple drug resistance, Drug resistance, Intensive care medicine, Internal medicine and Etest.
As a member of one scientific family, Magnus Unemo mostly works in the field of Intensive care medicine, focusing on Public health and, on occasion, Family medicine and Epidemiology.
The Virology study which covers Sexually transmitted disease that intersects with Antibacterial agent.
He most often published in these fields:
- Neisseria gonorrhoeae (56.96%)
- Microbiology (42.61%)
- Antibiotic resistance (35.12%)
What were the highlights of his more recent work (between 2018-2021)?
- Neisseria gonorrhoeae (56.96%)
- Antibiotic resistance (35.12%)
- Azithromycin (16.27%)
In recent papers he was focusing on the following fields of study:
Magnus Unemo mainly focuses on Neisseria gonorrhoeae, Antibiotic resistance, Azithromycin, Antimicrobial and Microbiology.
The concepts of his Neisseria gonorrhoeae study are interwoven with issues in Ceftriaxone, Cefixime, Cephalosporin, Multilocus sequence typing and Etest.
Magnus Unemo has researched Cefixime in several fields, including Ciprofloxacin and Epidemiology.
His Antibiotic resistance research is multidisciplinary, incorporating elements of Internal medicine, Mycoplasma genitalium, Public health, Gonorrhea and Drug resistance.
His studies in Drug resistance integrate themes in fields like Sexually transmitted disease and Intensive care medicine.
His research investigates the link between Microbiology and topics such as Efflux that cross with problems in Neisseria.
Between 2018 and 2021, his most popular works were:
- Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. (269 citations)
- World Health Organization Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): review of new data and evidence to inform international collaborative actions and research efforts (56 citations)
- 2019 European guideline on the management of lymphogranuloma venereum (28 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
